Impact of functional gastrointestinal disorders on survival in the community

American Journal of Gastroenterology

Volumn 105, Issue 4, 2010, Pages 822-832

  Chang, Joseph Y ^a   Locke, G Richard ^a   McNally, Meredythe A ^a   Halder, Smita L ^a   Schleck, Cathy D ^b   Zinsmeister, Alan R ^b   Talley, Nicholas J ^a,c  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; CAUSE OF DEATH; CHRONIC DIARRHEA; CLINICAL FEATURE; CONSTIPATION; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RESIDENT; SELF REPORT; SURVIVAL; UNIVARIATE ANALYSIS;

CAUSE OF DEATH; COHORT STUDIES; COLONIC DISEASES, FUNCTIONAL; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MINNESOTA; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 77950519595     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.40     Document Type: Article

References (57)

1. Halder SL, Locke GR III, Schleck CD et al. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007; 133: 799-807.
2. Switz DM. What the gastroenterologist does all day. A survey of a state society's practice. Gastroenterology 1976; 70: 1048-1050
3. Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 1987; 92: 1282-1284
4. Drossman DA, Li Z, Andruzzi E et al. US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-1580
5. Talley NJ, Zinsmeister AR, Melton LJ III. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995; 142: 76-83.
6. Drossman DA. Functional GI disorders: what's in a name? Gastroenterology 2005; 128: 1771-1772
7. Christensen J. Heraclides or the physician. Gastroenterol Int 1990; 3: 45-48
8. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-1390
9. Jones MP, Dilley JB, Drossman D et al. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil 2006; 18: 91-103.
10. Johnanson JF, Sonnenberg A, Koch TR. Clinical epidemiology of chronic constipation. J Clin Gastroenterol 1989; 11: 525-536
11. Brandt LJ, Bjorkman D, Fennerty MB et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002; 97: S7-26.
12. Stewart WF, Liberman JN, Sandler RS et al. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 1999; 94: 3530-3540
13. Sandler RS, Stewart WF, Liberman JN et al. Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci 2000; 45: 1166-1171
14. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004; 19: 643-654
15. Sandler RS, Everhart JE, Donowitz M et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500-1511
16. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002; 16: 1171-1185
17. Akehurst RL, Brazier JE, Mathers N et al. Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics 2002; 20: 455-462
18. Halder SL, Locke GR III, Talley NJ et al. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based casecontrol study. Aliment Pharmacol Ther 2004; 19: 233-242
19. Longstreth GF, Yao JF. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004; 126: 1665-1673
20. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 1140-1156
21. Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil 2008; 20 (Suppl 1): 121-129
22. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71: 266-274
23. Talley NJ, Zinsmeister AR, Schleck CD et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259-1268
24. Talley NJ, Weaver AL, Zinsmeister AR et al. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992; 136: 165-177
25. Talley NJ, Weaver AL, Zinsmeister AR. Smoking, alcohol, and nonsteroidal anti-infl ammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups. Am J Gastroenterol 1994; 89: 524-528
26. Talley NJ, Fett SL, Zinsmeister AR et al. Gastrointestinal tract symptoms and selfreported abuse: a population-based study. Gastroenterology 1994; 107: 1040-1049
27. Locke GR III, Zinsmeister AR, Talley NJ et al. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000; 75: 907-912
28. Locke GR III, Weaver AL, Melton LJ III et al. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol 2004; 99: 350-357
29. Vege SS, Locke GR III, Weaver AL et al. Functional gastrointestinal disorders among people with sleep disturbances: a population-based study. Mayo Clin Proc 2004; 79: 1501-1506
30. Delgado-Aros S, Locke GR III, Camilleri M et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol 2004; 99: 1801-1806
31. Talley NJ, Phillips SF, Wiltgen CM et al. Assessment of functional gastrointestinal disease: the Bowel Disease Questionnaire. Mayo Clin Proc 1990; 65: 1456-1479
32. Talley NJ, Phillips SF, Melton J III et al. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671-674
33. Attanasio V, Andrasik F, Blanchard EB et al. Psychometric properties of the SUNYA revision of the Psychosomatic Symptom Checklist. J Behav Med 1984; 7: 247-257
34. Locke GR, Talley NJ, Weaver AL et al. A new questionnaire for gastroesophageal refl ux disease. Mayo Clin Proc 1994; 69: 539-547
35. O ' Keefe EA, Talley NJ, Tangalos EG et al. A bowel symptom questionnaire for the elderly. J Gerontol 1992; 47: M116-21.
36. Drossman D, Corazziari E, Talley NJ et al. In Associates D (ed). The Functional Gastrointestinal Disorders Rome III, 3rd edn. Degnon Associates, Inc.: McLean, VA, 2006.
37. Accurint ®, a LexisNexis® commercial location and research online service 2005. Retrieved from Accurint ® website http://www.accurint.com.
38. Rocca WA, Grossardt BR, de Andrade M et al. Survival patterns aft er oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006; 7: 821-828
39. Kyle RA, Therneau TM, Rajkumar SV et al. Incidence of multiple myeloma in Olmsted County, Minnesota: trend over 6 decades. Cancer 2004; 101: 2667-2674
40. Bambha K, Kim WR, Talwalkar J et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125: 1364-1369
41. Carlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383
42. Hall WH, Ramachandran R, Narayan S et al. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 2004; 4: 94.
43. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619
44. Saito YA, Schoenfeld P, Locke GR III. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002; 91: 1910-1915
45. Spiegel BM. The burden of IBS: looking at metrics. Curr Gastroenterol Rep 2009; 11: 265-269
46. Hillila MT, Siivola MT, Farkkila MA. Comorbidity and use of health-care services among irritable bowel syndrome suff erers. Scand J Gastroenterol 2007; 42: 799-806.
47. Longstreth GF, Wilson A, Knight K et al. Irritable bowel syndrome, health care use, and costs: a US managed care perspective. Am J Gastroenterol 2003; 98: 600-607
48. Longstreth GF, Yao JF. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004; 126: 1665-1673
49. Drossman DA, Morris CB, Schneck S et al. International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefi t. J Clin Gastroenterol 2009; 43: 541-550
50. Haycox A, Einarson T, Eggleston A. The healTheconomic impact of upper gastrointestinal symptoms in the general population: results from the Domestive/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 1999; 231: 38-47.
51. Wallander MA, Johansson S, Ruigomez A et al. Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality. Fam Pract 2007; 10: 403-411
52. Jacobs EJ, White E. Constipation, laxative use, and colon cancer among middle-aged adults. Epidemiology 1998; 9: 385-391
53. Kune GA, Kune S, Field B et al. The role of chronic constipation, diarrhea, and laxative use in the etiology of large-bowel cancer. Data from the Melbourne Colorectal Cancer Study. Dis Colon Rectum 1988; 31: 507-512
54. Vobecky J, Caro J, Devroede G. A case-control study of risk factors for large bowel carcinoma. Cancer 1983; 51: 1958-1963
55. Roberts MC, Millikan RC, Galanko JA et al. Constipation, laxative use, and colon cancer in a North Carolina population. Am J Gastroenterol 2003; 98: 857-864
56. Watanabe T, Nakaya N, Kurashima K et al. Constipation, laxative use and risk of colorectal cancer: The Miyagi Cohort Study. Eur J Cancer 2004; 40: 2109-2115
57. Von Blumenthal J, Choung R, Locke GR et al. Diff erences between nonrespondents and respondents in bowel disease surveys in Olmsted County residents. Neurogastroenterol Motil 2008; s1: 138.